Business Context and Reporting Period
Company: OncoGenex Pharmaceuticals, Inc. (Note: Request metadata lists "ACHIEVE LIFE SCIENCES, INC.", but the filing text identifies the registrant as OncoGenex Pharmaceuticals, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: March 11, 2014
Reporting Period: Fourth quarter and full year ended December 31, 2013.
Key Financial Metrics
This Form 8-K serves as a notification of the issuance of a press release regarding financial results. The filing text itself does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the attached press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
The filing does not detail specific material changes or comparative financial data within the body of the report. It references the announcement of results for the period ended December 31, 2013, but does not quantify changes versus prior periods.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It solely references the existence of a press release containing the results.
Investor Verification Checklist
- Verify the specific financial results (revenue, net loss, cash position) by reviewing the attached press release (Exhibit 99.1) referenced in the filing.
- Confirm the company name discrepancy between the request metadata ("ACHIEVE LIFE SCIENCES, INC.") and the filing registrant ("ONCOGENEX PHARMACEUTICALS, INC.").
- Review the full text of the press release for any guidance or operational updates not summarized in this 8-K.